Lack Of Funding and Political Will Hinders Hong Kong’s Untapped Drug Discovery Research – ChinaBio Investor Forum
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Generally overshadowed by Singapore or Taiwan as a pharmaceutical and biotech center in Southeast Asia, Hong Kong has deep reserves of untapped knowledge and intellectual property
You may also be interested in...
Hong Kong and Australia Biotech Groups Boost Cooperation
The two groups hope member companies will benefit from Australia's expertise and Hong Kong's start-up scene.
Funding Crisis Hits China Life Sciences Industry, But China Is Faring Better Than The West
HONG KONG - Pitching her company to a group of potential investors in Hong Kong during the ChinaBio Investor Forum, Carrie Yuen painted a glowing picture of the potential of the Chinese market for medical devices
Funding Crisis Hits China Life Sciences Industry, But China Is Faring Better Than The West
HONG KONG - Pitching her company to a group of potential investors in Hong Kong during the ChinaBio Investor Forum, Carrie Yuen painted a glowing picture of the potential of the Chinese market for medical devices